0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letters |

Perivascular Epithelioid Cell Tumor of the Orbit FREE

Rainer Guthoff, MD; Tanja Guthoff, MD; Hans K. Mueller-Hermelink, MD; Johanna Sold-Darseff, MD; Eva Geissinger, MD
Arch Ophthalmol. 2008;126(7):1009-1011. doi:10.1001/archopht.126.7.1009.
Text Size: A A A
Published online

Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms comprising angiomyolipoma, lymphangiomyomatosis, and clear cell “sugar” tumor of the lung.1 In 1992, the term PEC was introduced to characterize distinct HMB45-positive cells that seemed to originate from blood vessel walls.2 Zamboni et al2 coined the term PEComa to describe a pancreatic clear cell sugar tumor lesion indistinguishable from lung clear cell sugar tumor. Recently, PEComas have been recognized at various sites, most often in middle-aged female patients.3 PEComas are characterized by typical chromosomal imbalances, suggesting PECs as distinct tumor cells.4

A single case of orbital PEComa has been reported in a 9-year old child.5 Here we report a PEComa in the orbit of a 54-year-old patient.

A 54-year-old male patient had a slowly progressing, painless swelling of the right temporal lower eyelid (Figure, A). Ophthalmological examination results of the healthy patient were otherwise normal. Orbital examination showed a soft fluctuant mass in the anterior inferotemporal orbit without overlying cutaneous changes. Orbital ultrasonography and computed tomography revealed a highly reflective, demarcated, hyperdense, contrast-enhancing, round lesion measuring 1.5 × 1.0 × 1.0 cm. The tumor with large feeder vessels was completely excised through an anterior orbitotomy with subciliary incision. No recurrence was detected during 17 months of follow-up.

Place holder to copy figure label and caption
Figure.

Clinicopathologic illustration. A, Swelling of the temporal lower eyelid (arrow). B, Macroscopic view of the yellow cut tumor surface. Scale bar indicates 0.1 cm. C, Trabeculae of epithelioid cells with clear to eosinophilic granular cytoplasm and mild lymphocytic infiltration around capillaries. Arrowhead indicates melanin granule (hematoxylin-eosin, original magnification ×200). Immunohistochemical staining with an antibody against CD31 shows the delicately arborizing capillaries (D), and staining against MART1 shows a distinct intracellular positivity in the tumor cells (E) (original magnification ×200).

Graphic Jump Location

The tumor was well delineated with a yellow cut surface (Figure, B). Light microscopy revealed a thin fibrous capsule and lymphocytic infiltrates (Figure, C). Solid and trabecular tumor cell aggregates showed intimate association with a ramified vascular network (Figure, D). The tumor cells were large with a clear to eosinophilic granular cytoplasm, round to oval nuclei with prominent nucleoli, and diffuse cell borders. Few cells contained melanin.

The melanocytic markers HMB45 and MART1 (melan A) (Figure, E) were strongly expressed, as were CD10 and CD68. Staining results for the pancytokeratin marker AE1/3, desmin, S-100 protein, CD31, actin, CD117, microphthalmia transcription factor, and chromogranin were negative. Vimentin stained single large cells likely not belonging to the tumor. The proliferation index (ki67) was very low (< 1%).

PEComas are composed of epithelioid, sometimes spindled cells with clear to eosinophilic granular cytoplasm in association with blood vessel walls. Characteristic features are HMB45 and MART1 expression, variable expression of muscle markers, and no cytokeratin or S-100 protein expression.6 In a recent comprehensive review,3 expression patterns were as follows: HMB45, 100% of PEComas; MART1, 41%; smooth muscle actin, 59%; S-100 protein, 11%; desmin, 31%; cytokeratin, 0%; and CD117, 33%. In our case, we detected melanocytic markers but no epithelial or smooth muscle markers.

The differential diagnosis of clear cell tumors is vast and comprises clear cell tumors of the lung, kidney, or female genital tract, which can be ruled out in the absence of epithelial markers.

As PEComas may produce melanin, malignant melanoma and pigmented paraganglioma are important differential diagnoses. Orbital melanoma is rare and includes primary orbital melanoma, secondary orbital melanoma by extension from adjacent structures, and metastatic melanoma. PEComas expressing S-100 protein usually also stain for smooth muscle antigen.3 In our case, the lack of nuclear polymorphism or S-100 protein staining and low mitotic activity make the diagnosis of melanoma unlikely. The epithelioid cell structure resembles paraganglioma, but the lack of neurosecretory granules or staining for chromogranin and S-100 protein argue against it.

PEComas generally show a benign course, although rare cases of malignant PEComas have been published.1 Necrosis, a high mitotic rate, a size larger than 7 cm, an infiltrative growth pattern, and a remarkable hypercellularity may indicate malignant PEComa.3 These characteristics were absent in our specimen. Because of its rarity, the clinical features, biological behavior, and best treatment of orbital PEComa are currently unclear. As most PEComas are benign, primary excision and regular follow-up seem reasonable.

Correspondence: Dr R. Guthoff, Department of Ophthalmology, University of Wuerzburg, Josef-Schneider-Strasse 11, 97080 Wuerzburg, Germany (r.guthoff@uni-wuerzburg.de).

Author Contributions: Dr R. Guthoff had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Financial Disclosure: None reported.

Additional Contributions: Christopher D. M. Fletcher, MD, FRCPath, confirmed the diagnosis.

Hornick  JLFletcher  CD PEComa: what do we know so far? Histopathology 2006;48 (1) 75- 82
PubMed Link to Article
Zamboni  GPea  MMartignoni  G  et al.  Clear cell “sugar” tumor of the pancreas: a novel member of the family of lesions characterized by the presence of perivascular epithelioid cells. Am J Surg Pathol 1996;20 (6) 722- 730
PubMed Link to Article
Folpe  ALMentzel  TLehr  HAFisher  CBalzer  BLWeiss  SW Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol 2005;29 (12) 1558- 1575
PubMed Link to Article
Pan  CCJong  YJChai  CYHuang  SHChen  YJ Comparative genomic hybridization study of perivascular epithelioid cell tumor: molecular genetic evidence of perivascular epithelioid cell tumor as a distinctive neoplasm. Hum Pathol 2006;37 (5) 606- 612
PubMed Link to Article
Iyengar  PDeangelis  DDGreenberg  MTaylor  G Perivascular epithelioid cell tumor of the orbit: a case report and review of the literature. Pediatr Dev Pathol 2005;8 (1) 98- 104
PubMed Link to Article
Vang  RKempson  RL Perivascular epithelioid cell tumor (“PEComa”) of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Am J Surg Pathol 2002;26 (1) 1- 13
PubMed Link to Article

Figures

Place holder to copy figure label and caption
Figure.

Clinicopathologic illustration. A, Swelling of the temporal lower eyelid (arrow). B, Macroscopic view of the yellow cut tumor surface. Scale bar indicates 0.1 cm. C, Trabeculae of epithelioid cells with clear to eosinophilic granular cytoplasm and mild lymphocytic infiltration around capillaries. Arrowhead indicates melanin granule (hematoxylin-eosin, original magnification ×200). Immunohistochemical staining with an antibody against CD31 shows the delicately arborizing capillaries (D), and staining against MART1 shows a distinct intracellular positivity in the tumor cells (E) (original magnification ×200).

Graphic Jump Location

Tables

References

Hornick  JLFletcher  CD PEComa: what do we know so far? Histopathology 2006;48 (1) 75- 82
PubMed Link to Article
Zamboni  GPea  MMartignoni  G  et al.  Clear cell “sugar” tumor of the pancreas: a novel member of the family of lesions characterized by the presence of perivascular epithelioid cells. Am J Surg Pathol 1996;20 (6) 722- 730
PubMed Link to Article
Folpe  ALMentzel  TLehr  HAFisher  CBalzer  BLWeiss  SW Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol 2005;29 (12) 1558- 1575
PubMed Link to Article
Pan  CCJong  YJChai  CYHuang  SHChen  YJ Comparative genomic hybridization study of perivascular epithelioid cell tumor: molecular genetic evidence of perivascular epithelioid cell tumor as a distinctive neoplasm. Hum Pathol 2006;37 (5) 606- 612
PubMed Link to Article
Iyengar  PDeangelis  DDGreenberg  MTaylor  G Perivascular epithelioid cell tumor of the orbit: a case report and review of the literature. Pediatr Dev Pathol 2005;8 (1) 98- 104
PubMed Link to Article
Vang  RKempson  RL Perivascular epithelioid cell tumor (“PEComa”) of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Am J Surg Pathol 2002;26 (1) 1- 13
PubMed Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

773 Views
5 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs